What is DCTH's health score?

DELCATH SYSTEMS, INC. (DCTH) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DCTH's estimated fair value?

Based on our 5-year discounted cash flow model, DELCATH SYSTEMS, INC.'s estimated fair value is $1.41 per share, representing a -86.8% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is DCTH undervalued or overvalued?

Our model currently rates DCTH as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DCTH... Refresh in a moment for the full analysis.

DELCATH SYSTEMS, INC. (DCTH)

Healthcare Overvalued low mixed

$10.67

Updated: 2026-06-06

TradeApes Score

Financial Strength

35 Weak

Operating Trend

93 Strong

Relative Value

35 Weak

Capital Allocation

30 Weak

Risk

35 Weak

Est. Fair Value $1.41

DCF Upside -86.8%

Sector Rank #172 of 6741

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.